Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2045 of 6351
-
Psoriasis drug risankizumab tested against rivals in large Real-World study
Disease control CompletedThis study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Brain wave monitor may sharpen sedation care for head injury patients
Knowledge-focused CompletedAn observational study to assess the BIS reported level of sedation of patients with traumatic brain injury in the ICU.
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can your own fat cells fix a torn rotator cuff?
Disease control OngoingRotator cuff disease is one of the most prevalent musculoskeletal conditions across the world. Patients with chronic rotator cuff tears often have substantial muscle atrophy and fatty infiltration. Surgical repair of the tear does not reverse the atrophy, and many patients contin…
Phase 2 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a common cancer drug prevent relapse after transplant?
Disease control Recruiting nowPrevious studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be well tolerated after SCT and help decrease rate of decreasing donor chimerism and hence decrease relapse without increasin…
Phase 2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
3-Week radiation blast could spare seniors from 7 weeks of treatment
Disease control CompletedThe purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers in patients 70 years of age and older. Standard radiation treatment for head and neck patients normally requires that the patient travel to the hospital daily fo…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Intense walking training boosts mobility in spinal cord injury patients
Symptom relief CompletedThe goal of this study is to identify the comparative efficacy of high-intensity walking training in individuals with chronic, motor incomplete spinal cord injury as compared to lower-intensity walking exercise.
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could a brain steroid help veterans with PTSD?
Symptom relief CompletedThis study seeks to determine if pregnenolone can improve symptoms of PTSD and other symptoms that commonly occur with PTSD in Iraq/Afghanistan-era Veterans. The total study duration for each participant is 10 weeks. Eligible Veterans with PTSD will receive either pregnenolone or…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Antidepressant drug could fight cancer fatigue
Symptom relief OngoingThis phase III trial studies how well bupropion works in reducing cancer related fatigue in cancer survivors. Cancer and its treatment can cause fatigue. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. It belongs to the family of drug…
Phase 3 • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could a vaccine before surgery stop breast cancer?
Vaccine Recruiting nowThis phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response …
Phase 1 • Sponsor: Mayo Clinic • Aim: Vaccine
Last updated Jun 27, 2026 09:10 UTC
-
Light exercise with a blood pressure cuff may rebuild leg muscle after knee replacement
Disease control OngoingThis study will determine the safety and efficacy of using blood-flow restriction exercise enhancement (B-FREE) to overcome persistent quadriceps muscle weakness that occurs following a total knee replacement (TKR).
Sponsor: Michigan Technological University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Liver pump chemo shows promise for colorectal cancer that spread
Disease control CompletedBackground: Many people with colorectal cancer get liver metastases. Standard treatment for this is a combination of chemotherapy drugs. Directing the chemotherapy to the liver may be effective. A device that does this a pump that delivers drugs over 2 weeks at constant rate int…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study has 2 parts. The first part of the study is done. The first part was open to adults with different types of advanced cancer (solid tumors). The second part is open to people with specific types of soft tissue sarcoma, advanced lung cancer, and cancer in the stomach, bl…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug cocktail aims to stop transplant rejection
Prevention CompletedThis is a single arm open label phase II clinical trial. Adult patients with hematological malignancies undergoing allogeneic HSCT from matched-related or unrelated donor are eligible for the study if they meet the standard criteria defined in the investigator's institutional sta…
Phase 2 • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Cash for breastfeeding? a new trial tests if incentives boost nursing rates
Prevention CompletedThis behavioral intervention trial will test whether a standard care breastfeeding intervention from the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) program plus monthly financial incentives contingent on observed breastfeeding will improve breas…
Sponsor: Philadelphia College of Osteopathic Medicine • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Can a new scale give voice to pain in the blind?
Diagnosis Stopped earlyThe aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New workshop aims to ease Veterans' return to civilian life
Symptom relief CompletedIn this proposal, the investigators extend their previous SPiRE feasibility and preliminary effectiveness study to examine STEP-Home efficacy in a RCT design. This novel therapy will target the specific needs of a broad range of underserved post-9/11 Veterans. It is designed to f…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Immunotherapy meets radiation in fight against recurrent meningioma
Disease control OngoingThis phase I/II trial studies the side effects and best dose of nivolumab when given together with multi-fraction stereotactic radiosurgery and to see how well they work with or without ipilimumab in treating patients with grade II-III meningioma that has come back (recurrent). I…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control Recruiting nowThis is a Phase I/II, dose-escalation and expansion study of NUC-7738 administered by intravenous infusion as a monotherapy and in combination with pembrolizumab. In Phase I, NUC-7738 monotherapy is evaluated across two administration schedules (weekly or fortnightly) in a dose-…
Phase 1/2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Tiny implant zaps bladder nerves to curb leaks
Symptom relief CompletedThe OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim™ implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.
Sponsor: BlueWind Medical • Aim: Symptom relief
Last updated Jun 26, 2026 17:37 UTC
-
Real-World tagrisso study shows promise for lung cancer patients
Disease control CompletedThis is a local, prospective, non-interventional, regulatory postmarketing surveillance study. The objectives of this study are to assess the safety and efficacy of single agent Tagrisso (Osimertinib, hereinafter "the study drug") in a real world setting according to the approved…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC